# LISS-0518 Phase 3 Final Review

| Field | Value |
|---|---|
| Scope | WP-0135 / LISS-0518 D02 bounded leakage-safe S02 model boundary |
| Phase reviewed | Phase 3 Refactor and final completion |
| Verdict | **READY / complete for the bounded D02 slice** |
| Isolation | `same_context` — weaker than `separate_context` |

## Canonical documents and files re-read

- [LISS-0518](../../issues/LISS-0518-s02-leakage-safe-model.md)
- [WP-0135](../../work-plans/WP-0135-s02-leakage-safe-model.md)
- [Scientific Workflow acceptance specification](../../specs/staqex-scientific-workflow-acceptance.md)
- [WP-0131](../../work-plans/WP-0131-scientific-workflow-program.md)
- `compiler/staqex/s02_leakage_safe_model.py`
- `tests/test_s02_leakage_safe_model_red.py`
- [LISS-0518 trace](../traces/2026-09-09-liss-0518-phase0.md)

## Findings and dispositions

### F1 — A real model implementation is not included

- Evidence: the module records split and provenance boundaries; model values
  remain provider-neutral inputs.
- Disposition: **out of scope for this bounded D02 slice**. Model-library and
  provider selection require a separate accepted design and are not needed to
  prove leakage safety.

### F2 — Prospective or clinical efficacy is not claimed

- Evidence: evaluation metrics are defined as descriptive MAE/RMSE and
  uncertainty coverage evidence only.
- Disposition: **out of scope for this bounded D02 slice**. Clinical/ADMET and
  prospective validation remain explicitly excluded.

### F3 — Leakage and provenance scenarios are observable

- Evidence: the acceptance suite covers valid fixed split, compound/group
  overlap quarantine, cutoff leakage quarantine, holdout-label exclusion,
  feature-fit leakage quarantine, and prediction uncertainty/applicability
  with FitRecord provenance.
- Disposition: **already closed with evidence**.

### F4 — Refactor preserves the public contract

- Evidence: fit-result construction and model revision handling were extracted
  into helpers; split partitions, diagnostic codes, FitRecord fields, and
  Prediction fields remain unchanged.
- Disposition: **already closed with evidence**.

## Deterministic verification

- D02 direct smoke checks: **passed**.
- Python compilation: **passed**.
- `git diff --check`: **passed**.
- Document lifecycle check: **passed**.
- pytest: unavailable locally because pytest is not installed; CI remains the
  complete pytest execution environment.

## Reviewer empathy summary

The public boundary is intentionally small: a caller supplies a predeclared
split and receives either an accepted provenance record or a fail-closed
diagnostic. Holdout data is not silently moved or relabeled, and predictions
retain uncertainty and applicability without becoming measurements.

## Final disposition

The approved D02 slice is complete. Real model selection, prospective assay
validation, and provider integration are separate future work. The next
planned item is WP-0136 / LISS-0519 classical batch baseline.
